Tear Sheet
Company Overview
HTG’s mission is to advance the promise of precision medicine through innovative transcriptome-wide profiling technology designed to accelerate the development of diagnostics and hasten the discovery of novel drug candidates to effect lifechanging outcomes. Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery.
Events
Date | Event Details |
---|---|
Summary Toggle Jun 23, 2022 at 2:00 PM EDT | |
Summary Toggle May 12, 2022 at 4:30 PM EDT | |
Summary Toggle Mar 29, 2022 at 4:30 PM EDT | |
Summary Toggle Nov 10, 2021 at 4:30 PM EST | |
Summary Toggle Oct 14, 2021 |
Stock Quote
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Stock Chart
SEC Filings
Filing date | Description |
---|---|
Report of unscheduled material events or corporate event |
|
A preliminary proxy statement providing notification matters to be brought to a vote |
|
Statement of changes in beneficial ownership of securities |
|
Statement of changes in beneficial ownership of securities |
|
Statement of changes in beneficial ownership of securities |